The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-14-0242
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Cancer-Associated Epstein-Barr Virus BZLF1 Promoter Variant Enhances Lytic Infection

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

Epstein-Barr Virus Lytic Replication Is Controlled by Posttranscriptional Negative Regulation of BZLF1.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Identification of N-Acetylglucosaminyltranferase-Iv as a Modifier of Epstein-Barr Virus BZLF1 Activity

Open Journal of Genetics
2013English

Zidovudine-Based Lytic-Inducing Chemotherapy for Epstein–Barr Virus-Related Lymphomas

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

The Epstein-Barr Virus EBNA1 Protein

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2012English

Latency and Lytic Replication in Epstein–Barr Virus-Associated Oncogenesis

Nature Reviews Microbiology
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2019English

The Epstein-Barr Virus Nuclear Antigen Leader Protein Associates With Hsp72/Hsc73.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Unexpected Structure of Epstein–Barr Virus Lytic Cycle Activator Zta

Trends in Microbiology
VirologyInfectious DiseasesMicrobiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy